LXEO Collar Strategy
LXEO (Lexeo Therapeutics, Inc. Common Stock), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.
LXEO (Lexeo Therapeutics, Inc. Common Stock) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $452.3M, a beta of 1.53 versus the broader market, a 52-week range of 2.43-10.99, average daily share volume of 884K, a public-listing history dating back to 2023, approximately 75 full-time employees. These structural characteristics shape how LXEO stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.53 indicates LXEO has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a collar on LXEO?
A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot.
Current LXEO snapshot
As of May 15, 2026, spot at $5.09, ATM IV 17.00%, IV rank 0.00%, expected move 4.87%. The collar on LXEO below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this collar structure on LXEO specifically: IV regime affects collar pricing on both sides; compressed LXEO IV at 17.00% typically pushes the short call premium to roughly offset the long put cost, with a market-implied 1-standard-deviation move of approximately 4.87% (roughly $0.25 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LXEO expiries trade a higher absolute premium for lower per-day decay. Position sizing on LXEO should anchor to the underlying notional of $5.09 per share and to the trader's directional view on LXEO stock.
LXEO collar setup
The LXEO collar below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LXEO near $5.09, the first option leg uses a $5.34 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LXEO chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LXEO shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $5.09 | long |
| Sell 1 | Call | $5.34 | N/A |
| Buy 1 | Put | $4.84 | N/A |
LXEO collar risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium.
LXEO collar payoff curve
Modeled P&L at expiration across a range of underlying prices for the collar on LXEO. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use collar on LXEO
Collars on LXEO hedge an existing long LXEO stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
LXEO thesis for this collar
The market-implied 1-standard-deviation range for LXEO extends from approximately $4.84 on the downside to $5.34 on the upside. A LXEO collar hedges an existing long LXEO position with a protective put while financing the put cost via a short call; when the premiums roughly offset, the collar acts as a near-zero-cost insurance band around the current spot. Current LXEO IV rank near 0.00% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LXEO at 17.00%. As a Healthcare name, LXEO options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LXEO-specific events.
LXEO collar positions are structurally neutral (protective); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LXEO positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LXEO alongside the broader basket even when LXEO-specific fundamentals are unchanged. Always rebuild the position from current LXEO chain quotes before placing a trade.
Frequently asked questions
- What is a collar on LXEO?
- A collar on LXEO is the collar strategy applied to LXEO (stock). The strategy is structurally neutral (protective): A collar pairs long stock with a protective out-of-the-money put financed by a short out-of-the-money call, capping both tails of the position around the current spot. With LXEO stock trading near $5.09, the strikes shown on this page are snapped to the nearest listed LXEO chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are LXEO collar max profit and max loss calculated?
- Max profit roughly equals short-call strike minus cost basis plus net premium; max loss roughly equals cost basis minus long-put strike minus net premium. Breakeven shifts by the net premium. For the LXEO collar priced from the end-of-day chain at a 30-day expiry (ATM IV 17.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LXEO collar?
- The breakeven for the LXEO collar priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LXEO market-implied 1-standard-deviation expected move is approximately 4.87%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a collar on LXEO?
- Collars on LXEO hedge an existing long LXEO stock position; the long put sets a floor while the short call finances it, often run as a near-zero-cost hedge during expected volatility windows.
- How does current LXEO implied volatility affect this collar?
- LXEO ATM IV is at 17.00% with IV rank near 0.00%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.